First participant in US coronavirus vaccine trial to be given dose
by Hannah Devlin Science correspondent from on (#50RYM)
Human trial of vaccine created by Moderna and the National Institutes of Health to begin in Seattle
The first participant in a clinical trial for a vaccine against Covid-19 will receive an experimental dose on Monday, according to a US government official.
The trial, taking place at the Kaiser Permanente Washington Health Research Institute in Seattle, will involve 45 young, healthy volunteers who will be given shots of the vaccine.
Continue reading...